BEEPEN-VK Drug Patent Profile
✉ Email this page to a colleague
When do Beepen-vk patents expire, and what generic alternatives are available?
Beepen-vk is a drug marketed by Glaxosmithkline and is included in two NDAs.
The generic ingredient in BEEPEN-VK is penicillin v potassium. There are ninety-two drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the penicillin v potassium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Beepen-vk
A generic version of BEEPEN-VK was approved as penicillin v potassium by CHARTWELL RX on November 23rd, 1988.
Summary for BEEPEN-VK
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 65 |
Patent Applications: | 1,687 |
Formulation / Manufacturing: | see details |
DailyMed Link: | BEEPEN-VK at DailyMed |
US Patents and Regulatory Information for BEEPEN-VK
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glaxosmithkline | BEEPEN-VK | penicillin v potassium | FOR SOLUTION;ORAL | 062270-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Glaxosmithkline | BEEPEN-VK | penicillin v potassium | TABLET;ORAL | 062273-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Glaxosmithkline | BEEPEN-VK | penicillin v potassium | FOR SOLUTION;ORAL | 062270-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Glaxosmithkline | BEEPEN-VK | penicillin v potassium | TABLET;ORAL | 062273-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |